Analgesics and Anti-inflammatory Drugs Practice Questions

Q: Anti-histone antibodies are characteristic of which condition?

Drug-induced lupus erythematosus. **Explanation:** **Anti-histone antibodies** are the hallmark serological marker for **Drug-induced Lupus Erythematosus (DILE)**. While Anti-nuclear antibodies (ANA) are positive in both systemic and drug-induced lupus, anti-histone antibodies are found in >95% of DILE cases but only about 50% of Systemic Lupus Erythematosus (SLE) cases. **Analysis of Options:** * **A. Drug-induced Lupus Erythematosus (Correct):** DILE is a lupus-like syndrome caused by the chronic use of certain drugs. It typically presents with fever, malaise, arthralgia, and serositis, but notably lacks the renal and CNS involvement seen in idiopathic SLE. * **B & C. Cardiac Lupus and Lupus Nephritis:** These are systemic manifestations of idiopathic SLE. In these conditions, **Anti-dsDNA** antibodies are highly specific and correlate with disease activity (especially renal involvement), whereas anti-histone antibodies are non-specific. * **D. Mixed Connective Tissue Disease (MCTD):** The characteristic serological marker for MCTD is **Anti-U1 RNP** antibody. **High-Yield Clinical Pearls for NEET-PG:** * **Common offending drugs (Mnemonic: SHIPP):** **S**ulfonamides, **H**ydralazine (highest risk), **I**soniazid, **P**rocainamide (highest frequency), and **P**henytoin. Other notable drugs include Minocycline and Anti-TNF alpha agents. * **Metabolism Link:** DILE is more common in **slow acetylators** (due to the genetically determined N-acetyltransferase enzyme deficiency). * **Key Difference:** Unlike SLE, DILE symptoms usually resolve upon discontinuation of the offending drug. * **Serology:** ANA is positive (sensitive), Anti-histone is positive (specific for DILE context), but **Anti-dsDNA and Hypocomplementemia (low C3/C4) are typically absent.**

Q: Which NSAID undergoes enterohepatic circulation?

Piroxicam. ### Explanation **Correct Option: B. Piroxicam** **Mechanism and Concept:** Piroxicam is a long-acting non-selective COX inhibitor belonging to the **Oxicam** class. The primary reason for its exceptionally long half-life (approximately 50 hours) is its extensive **enterohepatic circulation**. After being metabolized in the liver and excreted into the bile, a significant portion of the drug is reabsorbed from the gastrointestinal tract back into the systemic circulation. This recycling mechanism allows for convenient **once-daily dosing**, which is a hallmark of Piroxicam. **Analysis of Incorrect Options:** * **A. Phenylbutazone:** This is a pyrazolone derivative. While it has a long half-life (up to 70 hours), it is primarily due to slow metabolic transformation and high plasma protein binding, not significant enterohepatic recycling. It is rarely used now due to the risk of agranulocytosis. * **C. Aspirin:** Aspirin is a salicylate that undergoes rapid hydrolysis to salicylic acid. It follows first-order kinetics at low doses and zero-order kinetics at high doses, but it does not undergo significant enterohepatic circulation. * **D. Ibuprofen:** A propionic acid derivative with a very short half-life (approx. 2 hours). It is rapidly metabolized and excreted in the urine, requiring frequent dosing (3–4 times daily). **High-Yield Facts for NEET-PG:** * **Longest acting NSAID:** Piroxicam (due to enterohepatic circulation). * **Shortest acting NSAID:** Diclofenac or Ibuprofen. * **Clinical Pearl:** Because of its long half-life, Piroxicam takes about 7–10 days to reach steady-state plasma concentrations. It is also associated with a higher risk of **GI mucosal toxicity** and Peptic Ulcer Disease compared to other NSAIDs. * **Other drugs with Enterohepatic Circulation:** Morphine, Estrogen, Chloramphenicol, and Indomethacin (another NSAID that undergoes this process, though less prominently than Piroxicam).

Q: All of the following immunosuppressives cause profound myelosuppression except?

Cyclosporine. ### Explanation The core concept in this question is distinguishing between **cytotoxic immunosuppressants** and **calcineurin inhibitors**. **Why Cyclosporine is the Correct Answer:** Cyclosporine is a **calcineurin inhibitor**. It works by binding to cyclophilin, which inhibits the phosphatase activity of calcineurin. This prevents the translocation of Nuclear Factor of Activated T-cells (NFAT), ultimately blocking the production of IL-2 and T-cell proliferation. Because its mechanism is highly specific to T-lymphocyte signaling and does not involve the inhibition of DNA synthesis or cell division in rapidly dividing cells, it is **not myelosuppressive**. Its primary toxicities are nephrotoxicity, gingival hyperplasia, and hirsutism. **Analysis of Incorrect Options:** * **Azathioprine & Mercaptopurine:** These are antimetabolites (purine analogs) that interfere with DNA synthesis. Since bone marrow cells are rapidly dividing, these drugs inherently cause significant **myelosuppression** (leukopenia and thrombocytopenia) as a primary side effect. * **Sirolimus (Rapamycin):** While it is not a calcineurin inhibitor (it is an mTOR inhibitor), it is well-known for causing **thrombocytopenia** and anemia as common side effects, making it more myelosuppressive than cyclosporine. **High-Yield NEET-PG Pearls:** * **Calcineurin Inhibitors (Cyclosporine, Tacrolimus):** Mnemonic for Cyclosporine side effects: **"6 H's"** — **H**ypertension, **H**yperlipidemia, **H**yperkalemia, **H**irsutism, **H**yperplasia of gums, and **H**epatotoxicity (plus Nephrotoxicity). * **Tacrolimus vs. Cyclosporine:** Tacrolimus is more potent and does *not* cause hirsutism or gingival hyperplasia (it may cause alopecia instead). * **Drug Interaction:** Azathioprine/6-MP levels increase dangerously when co-administered with **Allopurinol** (due to Xanthine Oxidase inhibition), leading to life-threatening bone marrow suppression.

Q: The immunosuppressant action of cyclosporine appears to be due to which of the following mechanisms?

Inhibition of gene transcription of interleukins. ### Explanation **Mechanism of Action (The Correct Answer):** Cyclosporine is a **calcineurin inhibitor**. Under normal physiological conditions, when a T-cell is activated, intracellular calcium increases and binds to **calmodulin**. This complex activates calcineurin, a phosphatase that dephosphorylates **NFAT** (Nuclear Factor of Activated T-cells). Dephosphorylated NFAT enters the nucleus to promote the **transcription of interleukin genes**, primarily **IL-2**, which is essential for T-cell proliferation. Cyclosporine binds to its cytoplasmic receptor, **cyclophilin**, and this complex inhibits calcineurin. Consequently, NFAT remains phosphorylated, cannot enter the nucleus, and the transcription of IL-2 and other cytokines (IL-3, IFN-gamma) is inhibited. **Analysis of Incorrect Options:** * **Option A:** Cyclosporine actually **suppresses** cell-mediated immunity; it does not activate NK cells. * **Option B:** This describes the action of anti-inflammatory drugs like antihistamines or NSAIDs. Cyclosporine acts upstream by preventing the production of cytokines rather than blocking their peripheral tissue effects. * **Option D:** Cyclosporine does not interfere with the initial MHC-antigen recognition by the T-cell receptor; it blocks the subsequent intracellular signaling cascade. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** For prophylaxis of graft-versus-host disease in organ transplantation. * **Adverse Effects (The "H" Mnemonic):** **H**ypertension, **H**irsutism, **H**yperplasia of gums (gingival hyperplasia), **H**yperlipidemia, and **H**epatotoxicity. * **Most Serious Side Effect:** **Nephrotoxicity** (dose-related and the most common reason for dose limitation). * **Metabolism:** Metabolized by **CYP3A4**; beware of interactions with grapefruit juice (inhibitor) or Rifampicin (inducer).

Q: Allopurinol is used in the treatment of which of the following conditions?

Gout. **Explanation:** **Correct Answer: B. Gout** Allopurinol is the drug of choice for the long-term management of **chronic gout**. It is a **Hypoxanthine analog** that acts as a potent **Xanthine Oxidase inhibitor**. By inhibiting this enzyme, it prevents the conversion of hypoxanthine to xanthine and xanthine to uric acid, thereby reducing serum urate levels (Hypouricemic agent). This prevents the deposition of monosodium urate crystals in joints and kidneys. **Why other options are incorrect:** * **A. Osteoarthritis:** This is a degenerative joint disease characterized by cartilage wear and tear. Treatment focuses on lifestyle modification, physical therapy, and analgesics like NSAIDs or intra-articular steroids, not urate-lowering therapy. * **C. Rheumatoid Arthritis (RA):** RA is an autoimmune inflammatory disorder. Management requires Disease-Modifying Anti-Rheumatic Drugs (DMARDs) like Methotrexate, Sulfasalazine, or biologicals (TNF-inhibitors) to suppress the immune response. * **D. Ankylosing Spondylitis:** This is a seronegative spondyloarthropathy primarily affecting the spine. Treatment involves NSAIDs, exercise, and TNF-alpha inhibitors. **NEET-PG High-Yield Pearls:** * **Acute Gout Warning:** Never start Allopurinol during an acute attack of gout, as a sudden change in urate levels can precipitate or worsen the flare. * **Drug Interactions:** Allopurinol inhibits the metabolism of **6-Mercaptopurine** and **Azathioprine**. If co-administered, the dose of these drugs must be reduced by 75% to avoid life-threatening bone marrow suppression. * **Adverse Effects:** The most serious side effect is **Allopurinol Hypersensitivity Syndrome** (including Stevens-Johnson Syndrome), which is strongly associated with the **HLA-B*5801** allele. * **Alternative:** **Febuxostat** is a non-purine selective inhibitor of xanthine oxidase used in patients intolerant to Allopurinol.

Q: Low doses of aspirin therapy is advised for all of the following conditions except?

Systemic Lupus Erythematosus (SLE). ### Explanation **1. Why Systemic Lupus Erythematosus (SLE) is the Correct Answer:** Low-dose aspirin (75–150 mg) acts as an antiplatelet agent by irreversibly inhibiting **COX-1**, thereby blocking the synthesis of **Thromboxane A2 (TXA2)**. While SLE is an autoimmune condition, low-dose aspirin is **not** a standard primary therapy for the disease itself. SLE management typically involves hydroxychloroquine, corticosteroids, or immunosuppressants. Aspirin is only indicated in SLE patients if they have secondary **Antiphospholipid Syndrome (APS)** to prevent thrombosis; however, as a general rule for SLE alone, it is not a routine indication. **2. Analysis of Other Options:** * **Post-Myocardial Infarction:** Low-dose aspirin is the gold standard for secondary prevention. It prevents further coronary artery occlusion by inhibiting platelet aggregation at the site of atherosclerotic plaque rupture. * **Pre-eclampsia:** Low-dose aspirin (started before 16 weeks of gestation) is used in high-risk pregnancies to improve the balance between prostacyclin and thromboxane, thereby reducing the risk of placental ischemia and hypertension. * **Intrauterine Growth Restriction (IUGR):** In cases where IUGR is caused by placental insufficiency or pre-eclampsia, low-dose aspirin improves uteroplacental blood flow and fetal growth outcomes. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Aspirin is the only NSAID that inhibits COX **irreversibly** via acetylation. * **Dose-Dependent Effect:** * *Low dose (75-150 mg):* Antiplatelet (TXA2 inhibition). * *Intermediate dose (300-2400 mg):* Analgesic and Antipyretic. * *High dose (>4 g):* Anti-inflammatory (used in Rheumatic fever). * **Zero-Order Kinetics:** Aspirin follows zero-order elimination at high/toxic doses. * **Contraindication:** Avoid in children with viral infections to prevent **Reye’s Syndrome**.

Q: FK-506 is used in which of the following conditions?

Organ transplant. **Explanation:** **FK-506**, also known as **Tacrolimus**, is a potent immunosuppressant belonging to the **calcineurin inhibitor** class. **Why Option A is correct:** Tacrolimus works by binding to an intracellular protein called **FK-binding protein (FKBP)**. This complex inhibits **calcineurin**, a phosphatase enzyme required for the activation of the nuclear factor of activated T-cells (NFAT). By preventing NFAT activation, it inhibits the transcription of **Interleukin-2 (IL-2)** and other cytokines, thereby suppressing T-cell proliferation. This mechanism is vital in preventing **allograft rejection** in organ transplant recipients (e.g., kidney, liver, or heart). **Why other options are incorrect:** * **B. Bronchial asthma:** Asthma is managed with bronchodilators and corticosteroids. While Tacrolimus suppresses immune responses, it is not a standard treatment for asthma. * **C. Diabetic diarrhea:** This is usually a result of autonomic neuropathy and is managed with glycemic control or symptomatic treatments like loperamide; Tacrolimus has no role here. * **D. Chemotherapeutic agent:** Tacrolimus is an immunosuppressant, not a cytotoxic drug used to kill cancer cells. **High-Yield Clinical Pearls for NEET-PG:** * **Potency:** Tacrolimus is roughly **10–100 times more potent** than Cyclosporine. * **Side Effects:** Unlike Cyclosporine, Tacrolimus does **not** cause hirsutism or gum hyperplasia. However, it has a higher incidence of **post-transplant diabetes mellitus (PTDM)** and neurotoxicity (tremors). * **Topical Use:** Tacrolimus ointment is highly effective for **Atopic Dermatitis**. * **Metabolism:** It is metabolized by **CYP3A4**; therefore, grapefruit juice can increase its toxicity.

Question 1

Tacrolimus inhibits the transcription of which Interleukin?

Accepted Answer

Interleukin-2

Answer

Interleukin-1

Answer

Interleukin-3

Answer

Interleukin-4

Question 2

Anti-histone antibodies are characteristic of which condition?

Accepted Answer

Drug-induced lupus erythematosus

Answer

Cardiac lupus erythematosus

Answer

Lupus nephritis

Answer

Mixed connective tissue disease

Question 3

Which NSAID undergoes enterohepatic circulation?

Accepted Answer

Piroxicam

Answer

Phenylbutazone

Answer

Aspirin

Answer

Ibuprofen

Question 4

All of the following immunosuppressives cause profound myelosuppression except?

Accepted Answer

Cyclosporine

Answer

Sirolimus

Answer

Azathioprine

Answer

Mercaptopurine

Question 5

The immunosuppressant action of cyclosporine appears to be due to which of the following mechanisms?

Accepted Answer

Inhibition of gene transcription of interleukins

Answer

Activation of Natural Killer (NK) cells

Answer

Blockade of tissue responses to inflammatory mediators

Answer

Interference with antigen recognition

Question 6

Renal papillary necrosis is commonly caused by which class of drugs?

Accepted Answer

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Answer

Cocaine

Answer

Heroin

Answer

Morphine

Question 7

Allopurinol is used in the treatment of which of the following conditions?

Accepted Answer

Gout

Answer

Osteoarthritis

Answer

Rheumatoid arthritis

Answer

Ankylosing spondylitis

Question 8

What is the best drug for chronic gout in a patient with renal impairment?

Accepted Answer

Naproxen

Answer

Probenecid

Answer

Allopurinol

Answer

Sulfinpyrazone

Question 9

Low doses of aspirin therapy is advised for all of the following conditions except?

Accepted Answer

Systemic Lupus Erythematosus (SLE)

Answer

Intrauterine Growth Restriction (IUGR)

Answer

Post myocardial infarction

Answer

Pre-eclampsia

Question 10

FK-506 is used in which of the following conditions?

Accepted Answer

Organ transplant

Answer

Bronchial asthma

Answer

Diabetic diarrhea

Answer

Chemotherapeutic agent

Analgesics and Anti-inflammatory Drugs — MCQs

Analgesics and Anti-inflammatory Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?